Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanolabor, d.d. - raztopina za injiciranje - vinblastin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pliva ljubljana d.o.o., ljubljana - raztopina za injiciranje - vinblastin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

valentis pharmaceuticals d.o.o. - raztopina za injiciranje - vinblastin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanolabor, d.d. - raztopina za injiciranje - vinblastin

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antineoplastična sredstva - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pierre fabre medicament - vinflunin - carcinoma, transitional cell; urologic neoplasms - antineoplastična sredstva - zdravilo javlor je indicirano v monoterapiji za zdravljenje odraslih bolnikov z napredovalim ali metastatskim prehodnim celičnim karcinomom urotelijskega trakta po okvari predhodnega režima, ki vsebuje platin. učinkovitost in varnost vinflunine še ni raziskano pri bolnikih s uspešnosti stanje ≥ 2.

Evropska unija - slovenščina - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alkaloid - int d.o.o. - indapamid - tableta s podaljšanim sproščanjem - indapamid 10 mg / 1 tableta - indapamid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

flekainidijev acetat - tableta - flekainidijev acetat 100 mg / 1 tableta - flekainid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

flekainidijev acetat - tableta - flekainidijev acetat 50 mg / 1 tableta - flekainid